ADPL
Live / Registered — Registered (as of 05 Sept 2023)
What this means for you
Registered since 05 Sept 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97405280
- Registration number
- 7154375
- Mark type
- Stylized text
- Filed
- 11 May 2022
- Published for opposition
- 20 Jun 2023
- Registered
- 05 Sept 2023
- Attorney of record
- Meghna Prasad
Goods and services
- Class 005 — Pharmaceuticals: A full line of pharmaceuticals for the treatment of depression, hypertension, malaria, metastatic prostate cancer, benign prostatic hyperplasia, partial seizures in adults with epilepsy, attention deficit hyperactivity disorder (ADHD), heart failure in adults, heart failure in pediatric patients, atrial fibrillation in adults, edema associated with congestive heart failure, edema associated with cirrhosis of the liver, edema associated with nephrotic syndrome, steroid-induced edema, idiopathic edema, edema due to secondary hyperaldosteronism, acute enterocolitis, duodenal ulcer, and irritable bowel syndrome being irritable colon, spastic colon, mucous colitis; anti-inflammatory medicines, and immunosuppressive agents, namely, corticosteroids; pharmaceutical preparations for the treatment of cancers and abnormal cells; all of the foregoing excluding pharmaceutical preparations acting on the peripheral or central nervous system, surgical kits comprised of medical and surgical apparatus and instruments, and surgical implants comprised of human and animal tissue; all of the foregoing excluding anti-infective pharmaceutical preparations
Owner
- Mercury Pharma Group Limited, London, GB
- Mercury Pharma Group Limited, London, GB
- Mercury Pharma Group Limited, London, GB
Prosecution history
- 05 Sept 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 05 Sept 2023 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2023 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 20 Jun 2023 — PUBLISHED FOR OPPOSITION
- 31 May 2023 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 15 May 2023 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 May 2023 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 May 2023 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 04 May 2023 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 04 May 2023 — ASSIGNED TO LIE
- 02 Feb 2023 — TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
- 24 Jan 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 24 Jan 2023 — LETTER OF SUSPENSION E-MAILED
- 24 Jan 2023 — SUSPENSION LETTER WRITTEN
- 24 Jan 2023 — EXAMINER'S AMENDMENT ENTERED